Yutaka Fujioka

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Cerebrospinal Fluid

Top Venues

Neuro-oncology advances

This page only lists publications with an associated author ORCID identifier.

Publications

Ryosuke Otsuji, Nobuhiro Hata, Hidetaka Yamamoto, Daisuke Kuga, Ryusuke Hatae, Yuhei Sangatsuda, Yutaka Fujioka, Naoki Noguchi, Aki Sako, Osamu Togao, Tadamasa Yoshitake, Akira Nakamizo, Masahiro Mizoguchi, Koji Yoshimoto
Hemizygous deletion of cyclin-dependent kinase inhibitor 2A/B with p16 immuno-negative and methylthioadenosine phosphorylase retention predicts poor prognosis in IDH-mutant adult glioma. Neuro-oncology advances 6 (1) (2024)
Ryosuke Otsuji, Nobuhiro Hata, Hidetaka Yamamoto, Daisuke Kuga, Ryusuke Hatae, Yuhei Sangatsuda, Yutaka Fujioka, Naoki Noguchi, Aki Sako, Osamu Togao, Tadamasa Yoshitake, Akira Nakamizo, Masahiro Mizoguchi, Koji Yoshimoto
Hemizygous deletion of cyclin-dependent kinase inhibitor 2A/B with p16 immuno-negative and methylthioadenosine phosphorylase retention predicts poor prognosis in IDH-mutant adult glioma. Neuro-oncology advances 6 (1) (2024)
Ryosuke Otsuji, Yutaka Fujioka, Nobuhiro Hata, Daisuke Kuga, Yuhei Sangatsuda, Kosuke Takigawa, Yusuke Funakoshi, Aki Sako, Hidetaka Yamamoto, Akira Nakamizo, Masahiro Mizoguchi, Koji Yoshimoto
Liquid biopsy with multiplex ligation-dependent probe amplification targeting cell-free tumor DNA in cerebrospinal fluid from patients with adult diffuse glioma. Neuro-oncology advances 5 (1) (2022)
Ryosuke Otsuji, Yutaka Fujioka, Nobuhiro Hata, Daisuke Kuga, Yuhei Sangatsuda, Kosuke Takigawa, Yusuke Funakoshi, Aki Sako, Hidetaka Yamamoto, Akira Nakamizo, Masahiro Mizoguchi, Koji Yoshimoto
Liquid biopsy with multiplex ligation-dependent probe amplification targeting cell-free tumor DNA in cerebrospinal fluid from patients with adult diffuse glioma. Neuro-oncology advances 5 (1) (2022)